Pollini Daniele, Loffredo Rosa, Cardano Marina, Conti Luciano, Lattante Serena, Notarangelo Angelantonio, Sabatelli Mario, Provenzani Alessandro
Centre for Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38122 Trento, Italy.
Institute of Genomic Medicine, Catholic University School of Medicine, Largo F. Vito 1, 00168 Rome, Italy.
Stem Cell Res. 2018 Dec;33:146-150. doi: 10.1016/j.scr.2018.10.011. Epub 2018 Oct 6.
Fibroblasts isolated from an Amyotrophic Lateral Sclerosis (ALS)-patient carrying a mutation in Matrin-3 (p.Q66K -MATR3) gene were reprogrammed to the pluripotency stage by using non-integrating episomal plasmids. We generated the Q66K#44DRM induced pluripotent stem cell (iPSC) line that showed regular karyotype, expressed pluripotency-associated markers and were able to properly differentiate into the three germ layers. The heterozygous missense mutation in the MATR3 gene (p.Q66K), which is associated to ALS disease, was present in the generated iPSC line. Resource table.
从一名携带Matrin-3(p.Q66K -MATR3)基因突变的肌萎缩侧索硬化症(ALS)患者中分离出的成纤维细胞,通过使用非整合型附加体质粒被重编程到多能性阶段。我们生成了Q66K#44DRM诱导多能干细胞(iPSC)系,该细胞系显示出正常的核型,表达多能性相关标志物,并且能够正常分化为三个胚层。所生成的iPSC系中存在与ALS疾病相关的MATR3基因杂合错义突变(p.Q66K)。资源表。